Let’s get moving on AI-discovered treatments

By STEVEN ZECOLA Recursion Pharmaceuticals announced results today for one its AI-discovered treatments. I was pleased to see the large, sustained reduction in polyps attributable to its treatment for Familial Adenomatous Polyposis.  Recursions’ oral medication will be viewed by the traditional scientific and regulatory community as “promising”. On the other hand, I was disappointed not…

Read More

Ben Salter, SafeRide Health

Ben Salter is the Chief Product Officer of SafeRide Health. They are one of the biggest players in non-emergency medical transport (NEMT) working predominantly for health plans that have Medicaid or Medicare Advantage members. Getting people to their appointments is a big deal–think disabled or sick people who will miss clinical appointments if they can’t…

Read More

American Medicine’s Meagerness Paradox

By MARC-DAVID MUNK In our palliative medicine clinic in the working suburbs of Boston, my colleagues and I tend to some of the sickest patients in the city. Through the window, I can see the afflicted pull up to our squat building in family sedans, wheelchair vans, and subsidized municipal ride cars. Few drive themselves:…

Read More

Why The Epic-Health Gorilla Case Just Got Juicier

GuardDog Telehealth admitted it misrepresented its services to access patients’ health information, marking the first major concession in Epic’s lawsuit against Health Gorilla and other defendants accused of exploiting interoperability networks. The broader case is still ongoing. The post Why The Epic-Health Gorilla Case Just Got Juicier appeared first on MedCity News.

Read More